Menu Search
Equities

TenX Keane Acquisition

TENK:NMQ

TenX Keane Acquisition

Actions
  • Price (USD)11.18
  • Today's Change0.00 / 0.00%
  • Shares traded116.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 19:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		TENK:NMQ since
announced		Transaction
value
Citius Oncology IncAnnounced24 Oct 202324 Oct 2023Announced3.14%675.00m
Data delayed at least 15 minutes, as of May 08 2024 19:02 BST.

Institutional shareholders

46.62%Per cent of shares held by top holders
HolderShares% Held
Wolverine Asset Management LLCas of 31 Dec 2023566.71k6.34%
Cowen & Co. LLCas of 31 Mar 2024514.51k5.75%
Hudson Bay Capital Management LPas of 31 Dec 2023500.00k5.59%
W.R. Berkley Corp. (Investment Portfolio)as of 31 Dec 2023415.90k4.65%
Glazer Capital LLCas of 31 Dec 2023406.73k4.55%
Polar Asset Management Partners, Inc.as of 31 Dec 2023400.00k4.47%
Periscope Capital, Inc.as of 31 Dec 2023358.79k4.01%
RiverNorth Capital Management LLCas of 31 Dec 2023350.00k3.92%
Mizuho Securities USA LLCas of 31 Mar 2024331.00k3.70%
Koch Industries, Inc. (Investment Management)as of 31 Dec 2023325.00k3.64%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.